Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04199676 · ClinicalTrials.gov registry record
Immediate Postpartum Glucose Tolerance Testing
A clinical trial of Gestational Diabetes, sponsored by MemorialCare Health System.
- Recruiting
- Registry status
- 300
- Enrollment target
- 1
- Study location
NCT04199676: Recruiting study of Gestational Diabetes, sponsored by MemorialCare Health System.
NCT04199676 is a study of Gestational Diabetes that is actively recruiting participants, run by MemorialCare Health System. The registered enrollment target is 300 participants, roughly in line with the 315-participant average among 41 other Gestational Diabetes trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04199676, a study of Gestational Diabetes, is actively recruiting participants, sponsored by MemorialCare Health System.
- RECRUITING
- Registry status
- 300 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this study is to compare the accuracy of a 2hr glucose tolerance test administered during the postpartum hospitalization with the standard of care glucose tolerance testing (administered at 6 weeks postpartum). The primary hypothesis is that the glucose tolerance test administered in the postpartum period will be accurate and will improve compliance with postpartum testing for gestational diabetics.
Primary Outcome
Diagnostic accuracy between immediate postpartum glucose tolerance testing and gold standard testing
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Glucose tolerance test
Study Locations (1)
California
- Long Beach Memorial Medical Center/Miller Children's and Women's Hospital - Long Beach
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2020-09-01 |
| Est. Completion | 2026-12-31 |
What NCT04199676 shows while recruiting
NCT04199676 is an observational study that tracks outcomes without assigning an intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 315-participant average among 41 other Gestational Diabetes trials with a reported enrollment target.
The record links to 1 condition, with Gestational Diabetes appearing as the primary indexed condition, and to 1 intervention - of which Glucose tolerance test is the first listed.
NCT04199676 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT04199676 about?
NCT04199676 is a clinical study titled "Immediate Postpartum Glucose Tolerance Testing". The objective of this study is to compare the accuracy of a 2hr glucose tolerance test administered during the postpartum hospitalization with the standard of care glucose tolerance testing (administered at 6 weeks postpartum). The primary hypothesis is that the glucose tolerance test administered i...
What is the current status of trial NCT04199676?
This trial is currently recruiting. The enrollment target is 300 participants. The study started on 2020-09-01. Estimated completion is 2026-12-31.
What conditions does trial NCT04199676 study?
This clinical trial studies the following conditions: Gestational Diabetes.
What interventions are being tested in trial NCT04199676?
The interventions under investigation include: Glucose tolerance test (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04199676?
This trial is sponsored by MemorialCare Health System, which has 21 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04199676 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gestational Diabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04199676's enrollment target sits among peer trials
300 11th of 41 higher than 31 of 41 other Gestational Diabetes trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Gestational Diabetes trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Nutrition Optimization and Community Upliftment for Postpartum Recovery
RECRUITING · NA
-
Strict Versus Permissive Thresholds for Initiation of Pharmacotherapy in Gestational Diabetes (START 2)
RECRUITING · NA
-
Delivering HOPE (Helping Women Optimize Prenatal Equity)
RECRUITING · NA
-
iGlucose® Remote Patient Monitoring Device as an Adjunct to Routine Glucose Meter Devices for Glycemic Management and Control in Gestational Diabetes
RECRUITING · NA
-
Evaluating the Efficacy of GPT-based Nutrition and Diabetic Counseling in Gestational Diabetes Management: A Randomized Controlled Trial (AIM-GDM)
RECRUITING · NA
-
Growth Hormone Resistance of Beta-cells
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI